Don't Be Fooled by Their False Narrative - They're a Startup, Not a Mature Company
Pros
May be trying to increase clinical trials in underserved areas.
Cons
There is a lack of transparency by this company. They claim to have been around for more than 15 years, when in reality, they've only existed for 16 months. They are a spinoff from an oncology practice that was purchased by a private equity firm. There is no internal structure and no processes, procedures, or policies. The C-Suite is akin to the Keystone Cops or the Three Stooges. In keeping with the lack of transparency, there is also a lack of ethics and poor tone at the top. One of the C-suite executives hired his brother for a senior role (clear conflict of interest) that is sensitive to the Anti-Kickback Statute. Despite the fact that the company receives payments from government programs such as Medicare, it has no compliance program or educational training about the Anti-Kickback Statute, the False Claims Act, or any other federal guidance. This company is headed for a government investigation. Additionally, its salaries and benefits are far below industry standards, as the HR team seems unfamiliar with benchmarking by education, geography, etc. Employee turnover approximates 25%, even though the company has only been around for a short time. Unless you enjoy working in chaos and have little regard for doing business with integrity, avoid this company.
